NL1030503A1 - Octahydropyrrolo [3,4-c] pyrrole derivatives. - Google Patents

Octahydropyrrolo [3,4-c] pyrrole derivatives.

Info

Publication number
NL1030503A1
NL1030503A1 NL1030503A NL1030503A NL1030503A1 NL 1030503 A1 NL1030503 A1 NL 1030503A1 NL 1030503 A NL1030503 A NL 1030503A NL 1030503 A NL1030503 A NL 1030503A NL 1030503 A1 NL1030503 A1 NL 1030503A1
Authority
NL
Netherlands
Prior art keywords
octahydropyrrolo
pyrrole derivatives
pyrrole
derivatives
Prior art date
Application number
NL1030503A
Other languages
Dutch (nl)
Other versions
NL1030503C2 (en
Inventor
Charlotte Alice Louise Lane
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35985757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1030503(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04106044A external-priority patent/EP1671972A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of NL1030503A1 publication Critical patent/NL1030503A1/en
Application granted granted Critical
Publication of NL1030503C2 publication Critical patent/NL1030503C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL1030503A 2004-11-24 2005-11-23 Octahydropyrrolo [3,4-c] pyrrole derivatives. NL1030503C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04106044A EP1671972A1 (en) 2004-11-24 2004-11-24 Octahydropyrrolo[3,4-c]pyrrole derivatives
EP04106044 2004-11-24
EP05100474 2005-01-26
EP05100474 2005-01-26

Publications (2)

Publication Number Publication Date
NL1030503A1 true NL1030503A1 (en) 2006-05-29
NL1030503C2 NL1030503C2 (en) 2006-11-28

Family

ID=35985757

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1030503A NL1030503C2 (en) 2004-11-24 2005-11-23 Octahydropyrrolo [3,4-c] pyrrole derivatives.

Country Status (12)

Country Link
EP (1) EP1846409A1 (en)
JP (1) JP2008520644A (en)
AR (1) AR054707A1 (en)
CA (1) CA2587141A1 (en)
GT (1) GT200500340A (en)
NL (1) NL1030503C2 (en)
PA (1) PA8653801A1 (en)
PE (1) PE20061055A1 (en)
SV (1) SV2007002315A (en)
TW (1) TW200626600A (en)
UY (1) UY29221A1 (en)
WO (1) WO2006056848A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008083124A1 (en) 2006-12-28 2008-07-10 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
EP2460794A4 (en) * 2009-07-31 2013-01-23 Shionogi & Co Pharmaceutical composition containing fused hetero-ring derivative
JP5848251B2 (en) 2009-10-23 2016-01-27 ヤンセン ファーマシューティカ エヌ．ベー． Fused heterocyclic compounds as orexin receptor modulators
JP5759470B2 (en) 2009-10-23 2015-08-05 ヤンセン ファーマシューティカ エヌ．ベー． Disubstituted octahydropyrrolo [3,4-c] pyrrole as an orexin receptor modulator
EP2491034B1 (en) 2009-10-23 2013-12-18 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as orexin receptor modulators
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
HUE039713T2 (en) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitors for treating tinnitus
KR102559922B1 (en) 2016-03-10 2023-07-25 얀센 파마슈티카 엔.브이. The remedial method of the depression using the orexin -2 receptor antagonist
WO2019152883A1 (en) 2018-02-02 2019-08-08 Padforward Llc Inhibitors of protein arginine deiminases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2620341A (en) * 1949-03-24 1952-12-02 Burroughs Wellcome Co N,n-dialkyl-quinoline-4-carboxamidines
AU702752B2 (en) * 1995-05-11 1999-03-04 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
WO2002072548A2 (en) * 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
ATE325125T1 (en) * 2002-09-06 2006-06-15 Janssen Pharmaceutica Nv THIENOPYRROLYL AND FURANOPYRROLYL COMPOUNDS AND THEIR USE AS HISTAMINE H4 RECEPTOR LIGANDS
UA79309C2 (en) * 2002-09-06 2007-06-11 Janssen Pharmaceutica Nv Heterocyclic compounds
MXPA05002577A (en) * 2002-09-06 2005-09-20 Johnson & Johnson Use of histamine h4 receptor modulators for the treatment of allergy and asthma.

Also Published As

Publication number Publication date
TW200626600A (en) 2006-08-01
EP1846409A1 (en) 2007-10-24
GT200500340A (en) 2006-07-13
NL1030503C2 (en) 2006-11-28
SV2007002315A (en) 2007-02-16
CA2587141A1 (en) 2006-06-01
WO2006056848A1 (en) 2006-06-01
PE20061055A1 (en) 2006-11-09
PA8653801A1 (en) 2006-06-02
UY29221A1 (en) 2006-06-30
AR054707A1 (en) 2007-07-11
JP2008520644A (en) 2008-06-19

Similar Documents

Publication Publication Date Title
NL1030503A1 (en) Octahydropyrrolo [3,4-c] pyrrole derivatives.
PT1761542E (en) Octahydropyrrolo[3,4-c]pyrrole derivatives an their use as antiviral agents
DE122012000043I1 (en) Pyrrolo [2,3-B] pyridine derivatives as protein kinase inhibitors.
IS8403A (en) Pyrrole derivatives with bactericidal activity
DK1761533T3 (en) 1-Aza-bicyclo [3.3.1] nonanes
NO20053955D0 (en) Pyrazolo [1,5-A] pyrimidine derivatives
NL1025068A1 (en) Pyrrolopyrimidine derivatives.
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
DK1710241T3 (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1h-dibenz [2,3: 6,7] oxepino [4,5-c] pyrrole
NO20053748D0 (en) Pyrrolopyridazine derivatives.
NO20054330D0 (en) 8-substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives
IL183764A0 (en) Bicyclic pyrrole derivatives
NO20054331D0 (en) Substituted-8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives
ZA200805354B (en) Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
DE602004029045D1 (en) PYRROLO [3,4-C] PYRAZOLE DERIVATIVES WITH KINASE-HEMMENDER EFFECT
DE602005000528D1 (en) The steering lock
IS8195A (en) Installed pyrrole derivatives
HK1101856A1 (en) Pyrrolidine-3,4-dicarboxamide derivatives
ZA200610587B (en) 1-Heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
ZA200602947B (en) Pyrrol derivatives with antibacterial activity
GB0710111D0 (en) Pyrrolo [2, 1-C] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents
NL1026974A1 (en) Cargo bike.
SI1761542T1 (en) OCTAHYDROPYRROLO?á3,4-C?åPYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS
IL177362A0 (en) Fungicidal mixtures based on triazolopyrimidine derivatives
ES1058808Y (en) TRAVEL SUITCASE WITH PERFECTED WHEELS.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20060726

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20090601